NICOLE WOLFE: Open Payments
NPI 1609000454 · BUCYRUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 14 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Gilead Sciences, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Braeburn Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: REXULTI, VRAYLAR, SHINGRIX, TRINTELLIX, Qelbree, UZEDY, BRIXADI, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
